Revenue: The sum of all revenue fields included for a company's operating activities.
Lyra Therapeutics, Inc. (LYRA) had Revenue of $0.53M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
|
Revenue |
$0.53M |
$-22.45M |
|
-- |
|
$0.53M |
|
$24.06M |
|
$-23.52M |
|
$1.09M |
|
$-22.44M |
|
$-22.44M |
|
$-22.45M |
|
$-22.45M |
|
$-22.45M |
|
$-22.45M |
|
$-23.52M |
|
$-24.32M |
|
64.01M |
|
64.01M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$89.44M |
|
$3.78M |
|
$52.08M |
|
$141.53M |
|
$18.72M |
|
-- |
|
$45.30M |
|
$64.02M |
|
$77.50M |
|
$77.50M |
|
$77.50M |
|
60.97M |
|
| Cash Flow Statement Financials | |
$-22.45M |
|
$7.86M |
|
$8.64M |
|
$23.75M |
|
$17.79M |
|
$-5.95M |
|
$2.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4421.80% |
|
-4421.80% |
|
-- |
|
-4217.67% |
|
-4220.30% |
|
$-24.60M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-28.97% |
|
-28.97% |
|
-15.86% |
|
-28.97% |
|
$1.27 |
|
$-0.38 |
|
$-0.35 |
|